Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. - sprookjes - yvandenbroek - TriplyDB

Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.

Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.

http://www.wikidata.org/entity/Q41091448

about

Stem cell therapy for lower extremity diabetic ulcers: where do we stand?RETRACTED: Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection.Alpha-fetoprotein, identified as a novel marker for the antioxidant effect of placental extract, exhibits synergistic antioxidant activity in the presence of estradiol PlGF repairs myocardial ischemia through mechanisms of angiogenesis, cardioprotection and recruitment of myo-angiogenic competent marrow progenitors Placenta growth factor expression is regulated by hydrogen peroxide in vascular smooth muscle cells.Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy Immunoglobulin isotype isolated from human placental extract does not interfere in complement-mediated bacterial opsonization within the wound milieu.Photobiomodulation laser and pulsed electrical field increase the viability of the musculocutaneous flap in diabetic rats.Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease.Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix Proteolytic processing regulates placental growth factor activities Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells.Compartmentalizing VEGF-induced ERK2/1 signaling in placental artery endothelial cell caveolae: a paradoxical role of caveolin-1 in placental angiogenesis in vitro.Activated Transcription Factor 3 in Association with Histone Deacetylase 6 Negatively Regulates MicroRNA 199a2 Transcription by Chromatin Remodeling and Reduces Endothelin-1 Expression.Inhibition of placental growth factor improves surgical outcome of glaucoma surgery.Hox transcription factor regulation of adult bone-marrow-derived cell behaviour during tissue repair and regeneration.PlGF: a multitasking cytokine with disease-restricted activity.Age-related macular degeneration: beyond anti-angiogenesis.Placental growth factor (PlGF) as an angiogenic/inflammatory switcher: lesson from early pregnancy losses.Tissue-engineered provisional matrix as a novel approach to enhance diabetic wound healing.Placenta growth factor is a survival factor for human malignant mesothelioma cells.MicroRNA-203 contributes to skin re-epithelialization.Absence of placental growth factor blocks dextran sodium sulfate-induced colonic mucosal angiogenesis, increases mucosal hypoxia and aggravates acute colonic injury.Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGF.Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway.Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor.Placental growth factor increases regional myocardial blood flow and contractile function in chronic myocardial ischemia.A truncating mutation in the laminin-332α chain highlights the role of the LG45 proteolytic domain in regulating keratinocyte adhesion and migration.Nuclear factor-κB mediates placental growth factor induced pro-labour mediators in human placenta.VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury

P2860

Q26824484-16B224E8-7147-4B52-BAC2-DC1CE2B73C4F Q33583711-1919596B-DAAA-443E-A38A-C21B529ECA77 Q33748468-7A1E791D-7A7E-4067-8DBE-58E734E1612C Q34039453-0B627F29-D9DA-4BB0-81B0-CE02085E8361 Q34597511-08A7E90C-9E5F-4890-894D-B1B8AF645A61 Q35105257-B82969CF-74C8-4D25-A05B-7E9D60FB7C37 Q35605456-631E9321-3E44-4AC8-A1AA-660CED3EFD81 Q36268517-AA030812-DC26-4625-A145-1417CA056884 Q36275826-82FFA4A4-5E58-4108-A5DE-E46C402F0171 Q36712745-82BF7BE8-AC92-4651-84D9-1B3CC7ECBF2E Q36947711-FCDCA50B-E282-4481-B365-C032F2E4E1E1 Q37082000-7D10D59B-BC8E-4A05-8DF4-2196263DA60B Q37275834-20D831E7-2EA5-40DA-9960-E496AE2997B8 Q37332402-3955FB95-C7F7-4702-8A9F-884FFC8B4E98 Q37378630-BF46F000-8478-4C1D-92A3-1285CF3C369E Q37557535-185AF4AF-05C5-4B93-809D-12C9B4256DA5 Q37868026-A2409087-45BD-4962-92EA-D06BCFDEA163 Q38036234-BAEAD411-1F16-4843-A18F-43755D028221 Q38178644-F10DDF2B-9003-4E62-9882-8947A3E39797 Q39266458-ED8522C0-3CB3-4568-AD6B-82EE33D7F1D1 Q39677727-8F5753F7-E9D5-450C-8D72-5E24FC14B4A8 Q39841354-F66AE272-5899-475C-A832-6C802FE72F93 Q41871548-B3832DB7-F90E-404C-9C49-0380EAD34358 Q43168068-B42CF627-A980-4265-BA16-9AD25138AE5E Q44174033-1BD801AD-DD65-4CE6-95B2-C7A851EFABC5 Q48194235-BD38155C-3B3D-4FB5-89D1-D8054FD04E64 Q51689510-F0F7DDC7-02F6-41E7-986D-6D4E0989205E Q51838403-2490EFDF-26DC-4C29-8A1A-8FE276F2A1E5 Q52646554-696F5A42-6C5C-46E7-91C1-987413B09D20 Q54325060-63B8F059-F20A-4CA7-A00C-B404FA2FC1A8 Q58806294-7CFC3CB4-721A-49D5-BD6A-1455BB7F4776

P2860

Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.

http://www.wikidata.org/entity/Q41091448

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Placenta growth factor in diab ...... ion and therapeutic potential.

@en

type

label

Placenta growth factor in diab ...... ion and therapeutic potential.

@en

prefLabel

Placenta growth factor in diab ...... ion and therapeutic potential.

@en

P1433

Q41091448-E9E96F15-28EC-49A9-824C-C45D89FF1DD6

P1476

Q41091448-D91B4956-225E-4D5A-A9EE-11CBBF1417B9

P2093

Q41091448-1E3909C4-0B8C-4951-B5EC-766BC89AB78B

Q41091448-37BA771C-E9F6-4189-B60B-950AEA3F476D

Q41091448-72FADD14-BCD9-4123-B2EE-07EB6E5CC412

Q41091448-7445972D-58D3-4A1B-A087-C9C072E13F1A

Q41091448-C9D8ABFD-32BD-48EC-B276-0B860FA8EBB9

Q41091448-CE89E345-0588-428B-BAAF-453889EA0FEE

Q41091448-D3DEAD56-D0DA-46FB-8A59-F528C174F8F1

P2860

Q41091448-07E7F663-36E5-48CA-81B9-21825A30E8C8

Q41091448-091BD304-3071-45FA-A675-70D878D8E12A

Q41091448-0E150390-8AA8-403E-B2B3-8B03042CF80F

Q41091448-0F9A8F11-1CC6-4B39-82BD-207083DFB2CF

Q41091448-17B4ABC3-CED3-46FF-A9FE-A6658EB0AE6D

Q41091448-1CB18FD7-12F9-4FBB-B292-00597A354A84

Q41091448-2445B171-4550-41CB-95EC-99DFE4E9BFC9

Q41091448-3928A0BB-E846-426B-A25B-40BA4AF67D03

Q41091448-3C2ED8A2-19DD-4AD6-9B90-9F701D57F1FA

Q41091448-52AD4857-9706-4EE4-91FE-2187122B3F0B

P304

Q41091448-219A78EB-99B9-4344-AA1B-15C9624649EA

P31

Q41091448-D80D06B0-4F8E-4B09-B8AE-29B2E349FC39

P356

Q41091448-8800B953-2DA6-46EF-88F0-D341BD92E5D9

P407

Q41091448-3853CCE8-600B-4EA6-8A37-792721DBC7DE

P433

Q41091448-2751334F-55E6-4B57-94FF-BD714301C042

P478

Q41091448-9B72A980-D752-4DB3-972D-E1C32E661A3A

P50

Q41091448-4481B3FB-3690-4CC0-B9BE-25DE133CD12A

Q41091448-985CA00F-CB7B-4068-8586-EC609E3E9D98

Q41091448-E4144CE0-0845-4DAD-B35D-DE707D6B8787

P577

Q41091448-114806A6-E63D-4137-B19B-2B68E9D9EE24

P5875

Q41091448-E61CD60F-C573-4346-90CA-D5C99929B760

P698

Q41091448-FC9E3289-C739-4FEE-8527-F3AEF593693C

P932

Q41091448-D3C037FA-E621-4EB4-B0D2-64D54FA29048

P356

AJPATH.2006.051314

P1433

The American Journal of Pathology

P1476

Placenta growth factor in diab ...... ion and therapeutic potential.

@en

P2093

Francesca Cianfarani

http://www.w3.org/2001/XMLSchema#string

Giovanna Zambruno

http://www.w3.org/2001/XMLSchema#string

Laura Brogelli

http://www.w3.org/2001/XMLSchema#string

Maurizio C Capogrossi

http://www.w3.org/2001/XMLSchema#string

Monica Napolitano

http://www.w3.org/2001/XMLSchema#string

Pedro Miguel Lacal

http://www.w3.org/2001/XMLSchema#string

Teresa Odorisio

http://www.w3.org/2001/XMLSchema#string

P2860

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

A new mathematical model for relative quantification in real-time RT-PCR

Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]

Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR

Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing

Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14

Regulation of wound healing by growth factors and cytokines

Wound healing--aiming for perfect skin regeneration

Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment

P304

1167-1182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2006.051314

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P50

Cristina M Failla

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6792064

http://www.w3.org/2001/XMLSchema#string

P698

17003476

http://www.w3.org/2001/XMLSchema#string

P932

1698842

http://www.w3.org/2001/XMLSchema#string